| Virtual Reality for Post Operative Pain (NCT03776344) | Babes-Bolyai University | 2018-10-10 |
| Risk Stratification Procedure for Thromboembolism Prophylaxis (NCT04031859) | Ministry of Health, Saudi Arabia | 2018-10-10 |
| Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung Cancer (NCT03539536) | AbbVie | 2018-10-10 |
| A Single Inhalation Dose Study to Assess Efficacy, Pharmacokinetics (PK), Safety and Tolerability of AZD8871 in Patients With Long-term Lung Diseases. (NCT03645434) | AstraZeneca | 2018-10-10 |
| A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma (NCT03676946) | Lee's Pharmaceutical Limited | 2018-10-10 |
| Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma (NCT03680521) | Mirati Therapeutics Inc. | 2018-10-10 |
| DKN-01 Inhibition in Advanced Liver Cancer (NCT03645980) | Johannes Gutenberg University Mainz | 2018-10-10 |
| Mindfulness Training Plus Oxytocin Effects on Smoking Behavior (NCT03819231) | University of Southern California | 2018-10-10 |
| TEAM (Thiotepa, Etoposide, Cytosar, Melphalan ) for AutoSCT in Lymphoma (NCT03346096) | Sheba Medical Center | 2018-10-09 |
| Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib (NCT03094052) | University of California, San Francisco | 2018-10-09 |
| Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer (NCT03704688) | Memorial Sloan Kettering Cancer Center | 2018-10-09 |
| Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy (NCT03702140) | Shinshu University | 2018-10-09 |
| A Phase 2 Randomised Controlled Trial to Evaluate Efficacy and Safety of Anaprazole in Patients With Duodenal Ulcers. (NCT04503629) | Sihuan Pharmaceutical Holdings Group Ltd. | 2018-10-09 |
| A Phase II Clinical Trial of Cediranib and Olaparib Maintenance in Advanced Recurrent Cervical Cancer (NCT04487587) | The Clatterbridge Cancer Centre NHS Foundation Trust | 2018-10-09 |
| Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of Age (NCT03698279) | Sanofi Pasteur, a Sanofi Company | 2018-10-09 |
| Preoperative Palbociclib in Patients With DCIS of the Breast That Are Candidates for Surgery (NCT03535506) | Georgetown University | 2018-10-08 |
| Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD) (NCT03216538) | Feramda | 2018-10-08 |
| Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma With Pathologic Stage I and Primary Tumor Than 4 cm (NCT03254004) | Samsung Medical Center | 2018-10-08 |
| Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G) (NCT06360588) | National Cancer Institute (NCI) | 2018-10-08 |
| Limb Remote Ischemic Conditioning and Cerebrovascular Reserve (NCT03589053) | Capital Medical University | 2018-10-08 |
| Effect of Neflamapimod on Brain Inflammation in Alzheimer's Disease Patients (NCT03435861) | University Hospital, Toulouse | 2018-10-08 |
| A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis (NCT03682705) | AbbVie | 2018-10-08 |
| A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202) (NCT03597295) | Incyte Corporation | 2018-10-08 |
| A Study of PLB1001 Enteric Capsules in the Treatment of sGBM/IDH Mutant Glioblastoma Patients With the ZM Fusion Gene (FUGEN). (NCT06105619) | Beijing Pearl Biotechnology Limited Liability Company | 2018-10-08 |
| Cetuximab and Vemurafenib Plus FOLFIRI for BRAF V600E Mutated Advanced Colorectal Cancer (IMPROVEMENT) (NCT03727763) | Shanghai Changzheng Hospital | 2018-10-08 |
| Improving the Outcome of High-risk Aggressive B-cell Lymphoma Patients With Nivolumab Maintenance Therapy (NCT03569696) | Meirav Kedmi MD | 2018-10-08 |
| Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer (NCT03532737) | Kuwait Cancer Control Center | 2018-10-07 |
| Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa (NCT04315025) | PT. Prodia Stem Cell Indonesia | 2018-10-07 |
| The Neuroprotective Effect of Remote Ischemic Conditioning in Ruptured Aneurysm Coiling Therapy (NCT03561311) | Capital Medical University | 2018-10-06 |
| Impact of Ketone Bodies and Epigallocatechin Gallate in Multiple Sclerosis (NCT03740295) | Fundación Universidad Católica de Valencia San Vicente Mártir | 2018-10-05 |
| Preoperative Application of Chlorhexidine to Reduce Infection With Cesarean Section After Labor (NCT03423147) | Angela Bianco | 2018-10-05 |
| Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699 (NCT03606408) | RECORDATI GROUP | 2018-10-05 |
| Vemurafenib, Cobimetinib, Atezolizumab, and Tiragolumab in Treating Patients With High-Risk Stage III Melanoma (NCT03554083) | Mayo Clinic | 2018-10-05 |
| A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment (NCT03428958) | NuCana plc | 2018-10-05 |
| JNJ-40346527 in Treating Participants With Relapsed or Refractory Acute Myeloid Leukemia (NCT03557970) | OHSU Knight Cancer Institute | 2018-10-05 |
| Evaluation of Third-line cART Regimen in Cambodia (3DICAM) (NCT03602690) | ANRS, Emerging Infectious Diseases | 2018-10-04 |
| Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease (NCT03625401) | Zhejiang Hisun Pharmaceutical Co. Ltd. | 2018-10-04 |
| Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide (NCT03411031) | H. Lee Moffitt Cancer Center and Research Institute | 2018-10-04 |
| A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma (NCT03711188) | Immodulon Therapeutics Ltd | 2018-10-04 |
| D-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (NCT03633123) | PolyPid Ltd. | 2018-10-04 |
| Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma (NCT03126630) | National Cancer Institute (NCI) | 2018-10-04 |
| Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine (NCT03609398) | U.S. Army Medical Research and Development Command | 2018-10-04 |
| A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy (NCT03608020) | BioMimetix JV, LLC | 2018-10-04 |
| A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD Patients (NCT03523728) | Genzyme, a Sanofi Company | 2018-10-04 |
| Nivolumab in Preventing Colon Adenomas in Participants With Lynch Syndrome and a History of Partial Colectomy (NCT03631641) | John Hays | 2018-10-04 |
| AMZ001 for the Treatment of Knee Osteoarthritis Symptoms (NCT03691844) | Amzell | 2018-10-04 |
| Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner (NCT03618134) | Jonsson Comprehensive Cancer Center | 2018-10-04 |
| Phase II Multicenter Study of Durvalumab and Olaparib in Platinum tReated Advanced Triple Negative Breast Cancer (DORA) (NCT03167619) | Duke University | 2018-10-04 |
| Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer (NCT03608046) | Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 2018-10-03 |
| An Efficacy and Safety Study of APX001 in Non-Neutropenic Patients With Candidemia (NCT03604705) | Basilea Pharmaceutica | 2018-10-03 |
| Pyramax in Asymptomatic Carriers of P. Falciparum Monoinfections (NCT03814616) | Shin Poong Pharmaceutical Co. Ltd. | 2018-10-03 |
| Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy (NCT03543189) | H. Lee Moffitt Cancer Center and Research Institute | 2018-10-03 |
| Lenvatinib and Pembrolizumab Simultaneous Combination Study (NCT03609359) | National Cancer Center Hospital East | 2018-10-03 |
| 4-aminopyridine Treatment for Nerve Injury From Radical Retro-Pubic Prostatectomy (NCT03658408) | University of Rochester | 2018-10-03 |
| Prevention of Thromboembolic Events in Total Knee Replacement Patients (NCT03393481) | Novartis Pharmaceuticals | 2018-10-03 |
| Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy) (NCT03682770) | Regeneron Pharmaceuticals | 2018-10-03 |
| Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD) (NCT03699384) | Memorial Sloan Kettering Cancer Center | 2018-10-03 |
| Treating Severe Brain-injured Patients With Apomorphine (NCT03623828) | University of Liege | 2018-10-03 |
| Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC (NCT03573947) | Jeffrey Clarke | 2018-10-02 |
| Pembrolizumab and EDP1503 in Advanced Melanoma (NCT03595683) | University of Chicago | 2018-10-02 |
| А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder (NCT04524975) | ChemRar Research and Development Institute, LLC | 2018-10-02 |
| Fluciclovine F18 PET/CT Imaging in Assessing Hormone-Naive Men With Prostate Cancer That Has Spread to the Bone (NCT03707184) | University of Utah | 2018-10-02 |
| Losartan for the Treatment of Pediatric NAFLD (NCT03467217) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2018-10-02 |
| NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue Sarcoma (NCT03524898) | Swiss Cancer Institute | 2018-10-02 |
| A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber (NCT03709121) | Aldeyra Therapeutics, Inc. | 2018-10-02 |
| Mind and Body Approaches to Pain Reduction in Youth With Migraine (NCT03472092) | Children's Hospital Medical Center, Cincinnati | 2018-10-02 |
| A Study Comparing Corticosteroids Alone Versus Corticosteroids and Extracorporal Photopheresis (ECP) as First-line Treatment of Standard II Acute Graft-versus-host Disease (NCT03605940) | Central Hospital, Nancy, France | 2018-10-01 |
| Vaginal Preparation With Chlorhexidine-alcohol vs. Povidine-iodine vs. Saline (NCT03640507) | Columbia University | 2018-10-01 |
| Efficacy and Safety of HQGZWWT Patients With Rheumatoid Arthritis (NCT03593837) | Cui xuejun | 2018-10-01 |
| Phase 2 Herniorrhaphy Study for Opioid Elimination (NCT03695367) | Heron Therapeutics | 2018-10-01 |
| Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer (NCT03742713) | Cristal Therapeutics | 2018-10-01 |
| Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors (NCT03530800) | University of Chicago | 2018-10-01 |
| A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors (NCT03665285) | NextCure, Inc. | 2018-10-01 |
| Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors. (NCT03544723) | MultiVir, Inc. | 2018-10-01 |
| Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic Patients (NCT03631004) | Instituto do Cancer do Estado de São Paulo | 2018-10-01 |
| IMPROVE Intervention Trial Implementing Non-invasive Circulating Tumor DNA Analysis to Optimize the Operative and Postoperative Treatment for Patients With Colorectal Cancer (NCT03748680) | Karen-Lise Garm Spindler | 2018-10-01 |
| Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension (NCT03528902) | Vanderbilt University Medical Center | 2018-10-01 |
| Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome (NCT03670160) | University of Tennessee Medical Center | 2018-10-01 |
| Effectiveness of Chiropractic Application for Acute Low Back Pain (NCT04110119) | Medipol University | 2018-10-01 |
| Effectiveness of Autologous Adipose-derived Stem Cells in the Treatment of Knee Cartilage Injury (NCT03955497) | Qilu Hospital of Shandong University | 2018-10-01 |
| Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients (NCT03474965) | Novartis Pharmaceuticals | 2018-10-01 |
| Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors (NCT03628131) | Samsung Medical Center | 2018-10-01 |
| Optimal Treatment of Veterans With PTSD and Comorbid OUD (NCT03605342) | VA Office of Research and Development | 2018-10-01 |
| Enhancing Self Regulation Among Smokers (NCT04161144) | Medical University of South Carolina | 2018-10-01 |
| Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function (NCT03618420) | University of Colorado, Denver | 2018-10-01 |
| Treatment of Hypertrophic Scars With Intradermal Botox (NCT03631368) | Roy G. Geronemus, M.D. | 2018-10-01 |
| Effect of Menopause Relief EP-40 in Women With Menopausal Symptoms (NCT03461380) | EuroPharma, Inc. | 2018-10-01 |
| Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer (NCT04060459) | Third Military Medical University | 2018-10-01 |
| Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment (NCT03536780) | Gachon University Gil Medical Center | 2018-10-01 |
| Anlotinib Plus Docetaxel for the Treatment of EGFR/ALK/ROS1 Mutation-negative Advanced Nonsquamous NSCLC (NCT03654027) | First Affiliated Hospital of Guangxi Medical University | 2018-10-01 |
| 35RC17_8826_NEPHROPAIN Phase APRES : Interest of the Equimolar Oxygen Nitride Mixture (MEOPA) in the Treatment of Pain in Patients Presenting to the Emergency Department for Suspected Renal Colic: a Study BEFORE AFTER (NCT03638921) | Rennes University Hospital | 2018-10-01 |
| ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer (NCT03402880) | City of Hope Medical Center | 2018-10-01 |
| tSMS in Essential Tremor (NCT03780426) | Fundación de investigación HM | 2018-10-01 |
| Imatinib for Multiple Sclerosis (MS) Relapses (NCT03674099) | Tomas Olsson | 2018-10-01 |
| Colchicine for Patients With Chagas´ Disease( B1 Stage) (NCT03704181) | University of Sao Paulo General Hospital | 2018-10-01 |
| Melatonin for Renal Protection in Patients Receiving Polymyxin B (NCT03725267) | Hospital de Clinicas de Porto Alegre | 2018-10-01 |
| Safety and Efficacy Assessments of Osalmid in Multiple Myeloma (NCT03670173) | Shanghai 10th People's Hospital | 2018-10-01 |
| Evaluation of Lycopene in the Treatment of Erosive Oral Lichen Planus (NCT04652739) | Nourhan M.Aly | 2018-10-01 |
| Use of Phenylbutyrate Therapy for Patients With Pyruvate Dehydrogenase Complex Deficiency. (NCT03734263) | Fondazione Telethon | 2018-10-01 |
| EGFR-TKIs Combine With Anlotinib as First-line Treatment for Patients With Advanced EGFR Mutation-positive NSCLC (NCT03720873) | Fujian Cancer Hospital | 2018-10-01 |